Arama Sonuçları - Patel, Luv
- Gösterilen 1 - 10 sonuçlar arası kayıtlar. 10
-
1
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway Yazar: Allen, Joshua E, Krigsfeld, Gabriel, Patel, Luv, Mayes, Patrick A, Dicker, David T, Wu, Gen Sheng, El-Deiry, Wafik S
Baskı/Yayın Bilgisi 2015Metin -
2
Posterior Vitreous Detachment and the Associated Risk of Retinal Toxicity with Intravitreal Melphalan Treatment for Retinoblastoma Yazar: Berry, Jesse L., Lee, Ramon, Patel, Luv, Le, Bao Han A., O'Fee, John, Jubran, Rima, Kim, Jonathan W.
Baskı/Yayın Bilgisi 2019Metin -
3
5-HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability Yazar: Ballou, Yessenia, Rivas, Alexandria, Belmont, Andres, Patel, Luv, Amaya, Clarissa N., Lipson, Shane, Khayou, Thuraieh, Dickerson, Erin B., Nahleh, Zeina, Bryan, Brad A.
Baskı/Yayın Bilgisi 2018Metin -
4
BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response Yazar: Sarosiek, Kristopher A., Chi, Xiaoke, Bachman, John A., Sims, Joshua J., Montero, Joan, Patel, Luv, Flanagan, Annabelle, Andrews, David W., Sorger, Peter, Letai, Anthony
Baskı/Yayın Bilgisi 2013Metin -
5
Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic: A Historical Cohort Study Yazar: Patel, Luv G., Peck, Travis, Starr, Matthew R., Ammar, Michael J., Khan, M. Ali, Yonekawa, Yoshihiro, Klufas, Michael A., Regillo, Carl D., Ho, Allen C., Xu, David
Baskı/Yayın Bilgisi 2021Metin -
6
Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects Yazar: Allen, Joshua E., Krigsfeld, Gabriel, Mayes, Patrick A., Patel, Luv, Dicker, David T., Patel, Akshal S., Dolloff, Nathan G., Messaris, Evangelos, Scata, Kimberly A., Wang, Wenge, Zhou, Jun-Ying, Wu, Gen Sheng, El-Deiry, Wafik S.
Baskı/Yayın Bilgisi 2013Metin -
7
Practice Patterns and Responsiveness to Simulated Common Ocular Complaints Among US Ophthalmology Centers During the COVID-19 Pandemic Yazar: Starr, Matthew R., Israilevich, Rachel, Zhitnitsky, Michael, Cheng, Qianqian E., Soares, Rebecca R., Patel, Luv G., Ammar, Michael J., Khan, M. Ali, Yonekawa, Yoshihiro, Ho, Allen C., Cohen, Michael N., Sridhar, Jayanth, Kuriyan, Ajay E.
Baskı/Yayın Bilgisi 2020Metin -
8
Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection Yazar: Price, Alexander M, Dai, Joanne, Bazot, Quentin, Patel, Luv, Nikitin, Pavel A, Djavadian, Reza, Winter, Peter S, Salinas, Cristina A, Barry, Ashley Perkins, Wood, Kris C, Johannsen, Eric C, Letai, Anthony, Allday, Martin J, Luftig, Micah A
Baskı/Yayın Bilgisi 2017Metin -
9
Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma Yazar: Amaya, Clarissa N., Perkins, Mariah, Belmont, Andres, Herrera, Connie, Nasrazadani, Arezo, Vargas, Alejandro, Khayou, Thuraieh, Montoya, Alexa, Ballou, Yessenia, Galvan, Dana, Rivas, Alexandria, Rains, Steven, Patel, Luv, Ortega, Vanessa, Lopez, Christopher, Chow, William, Dickerson, Erin B., Bryan, Brad A.
Baskı/Yayın Bilgisi 2018Metin -
10
Scleral Buckling for Primary Retinal Detachment: Outcomes of Scleral Tunnels versus Scleral Sutures Yazar: Starr, Matthew R., Ryan, Edwin H., Obeid, Anthony, Ryan, Claire, Gao, Xinxiao, Madhava, Malika L., Maloney, Sean M., Adika, Adam Z., Peddada, Krishi V., Sioufi, Kareem, Patel, Luv G., Ammar, Michael J., Forbes, Nora J., Capone Jr., Antonio, Emerson, Geoffrey G., Joseph, Daniel P., Eliott, Dean, Regillo, Carl D., Hsu, Jason, Gupta, Omesh P., Yonekawa, Yoshihiro, Study Group, for the Primary Retinal Detachment Outcomes (PRO)
Baskı/Yayın Bilgisi 2021Metin